NCT05251610|Completed
Loading search results
Sponsor study identifier
interventional
110
1 country
1
Study Start
November 2, 2020
Actual (reported)Primary Completion
April 30, 2021
Actual (reported)Study Completion
April 30, 2021
Actual (reported)Labour is usually physiologic, spontaneous and progressive, but occasionally, there may be the need for induction or augmentation of labour especially in nulliparous women, who are at increased risk of dysfunctional labour. Oxytocin traditionally has been used for induction and augmentation of labour however prolonged labour continued to occur with attendant sequelae. Newer agents like propranolol, with minimal to no maternal and fetal adverse effects in labour have been shown to decreases the duration of labour when used in synergy with oxytocin. However, the paucity of information on the use of propranolol in labour.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 30, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 2, 2020
Actual (reported)April 30, 2021
Actual (reported)April 30, 2021
Actual (reported)September 22, 2021
Actual (reported)February 23, 2022
Actual (reported)Induction/Augmentation delivery intervals at delivery
Labor acceleration at delivery
Time frame in minutes from the onset of initiation of Oxytocin to the delivery of the placenta
Maternal Blood pressure change in mmgh
Change over 30 minutes
Fetal heart rate change in seconds
Change over 30 minutes
Participants will receive 20mg of oral propranolol 10 minutes prior to initiation of augmentation or induction of labor with oxytocin
Participants had outright augmentation or induction of labor with oxytocin only
Participants will receive 20mg of oral propranolol 10minutes prior to initiation of augmentation or induction of labor with oxytocin
Participants will have outright augmentation or induction of labor with oxytocin
AEFUTHA
Abakaliki, Ebonyi State, 234, Nigeria
Freedman SB, Adler M, Seshadri R, Powell EC. Oral ondansetron for gastroenteritis in a pediatric emergency department. N Engl J Med. 2006 Apr 20;354(16):1698-705. doi: 10.1056/NEJMoa055119.
UGOJI DR DARLINGTON-PETER, PART 1
ALEX EKWUEME FEDERAL UNIVERSITY TEACHING HOSPITAL, ABAKALIKI, EBONYI STATE, NIGERIA
110 participants (actual enrollment reported by the registry).
First Submitted
September 22, 2021
First Posted
February 23, 2022
Study Start
November 2, 2020
Actual (reported)Heat Application to the Sacral Region and Pain Level During the First Stage of Labor
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Primary Completion
April 30, 2021
Actual (reported)Study Completion
April 30, 2021
Actual (reported)Last Updated
February 23, 2022
Record last verified: 2022-02
until after defence of the work
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: